Frontiers in Computational and Mathematical Medicine
Celebrating Siv Sivaloganathan’s Contributions to Mathematical Medicine
Description
In the ever-evolving landscape of healthcare and medical exploration, the "Frontiers in Computational and Mathematical Medicine" conference will serve as a vibrant catalyst for global collaboration and trailblazing innovation. This event will focus on the vital intersections of mathematics, computation, and medicine – pivotal in advancing medical science and enhancing patient care.
The integration of mathematical and computational approaches within the medical domain is nothing short of revolutionary. These disciplines offer powerful tools for modelling complex biological systems, analyzing large-scale medical data, and developing innovative treatment strategies. Our expectations are that, by convening the most influential minds worldwide, working in this interdisciplinary field, our conference will provide a nexus for a distinctive exchange of ideas, cutting-edge methodologies, and unprecedented collaborative possibilities. The conference will attempt to bridge the gap between theoretical research and practical medical applications, thereby pushing the boundaries of possibilities in diagnosis, treatment, and disease prevention.
This conference holds special importance, marking a quarter-century of exceptional contributions by Professor Siv Sivaloganathan of the University of Waterloo. As a founding Director of the Centre for Mathematical Medicine at the Fields Institute for Research in Mathematical Sciences in Toronto, Professor Sivaloganathan has been a catalyst for interdisciplinary research and synergy between the biomedical and mathematical sciences. The Centre has become a hotbed of substantial research activity since its inception and has witnessed a considerable expansion of Professor Sivaloganathan's original research program through impactful collaborations with clinicians.
Photos:
For remote participation, please use the following Zoom link: https://zoom.us/j/92759411430
Schedule
09:00 to 09:30 |
Inaugural Remarks
|
09:30 to 10:30 |
Stem cell dynamics and mutant invasion in the hematopoietic system of mice
Dominik Wodarz, University of California, Irvine |
10:30 to 11:00 |
Coffee Break
|
11:00 to 11:20 |
Modelling Cancer Radiotherapy:Fractional vs Ordinary Differential Equations
Kathleen Wilkie, Toronto Metropolitan University |
11:20 to 11:40 |
A Quantitative Systems Pharmacology Model to Study the Efficacy of Therapies for the Treatment of Autoimmune Disease
Michelle Przedborski, Certara |
11:40 to 12:00 |
Moving towards genomically-driven interventions in precision radiation oncology
Venkata Manem, Université Laval |
12:00 to 14:00 |
Lunch Break
|
14:00 to 15:00 |
Helen Byrne, University of Nottingham and University of Oxford |
15:00 to 15:20 |
Mathematical and computational medicine: from data to models and back
Andrew Dhawan, Cleveland Clinic |
15:20 to 15:40 |
Accelerating the Development of Solid Tumour Therapies through QSP
Cameron Meaney, Simulations Plus Inc |
15:40 to 16:00 |
Translational PK/PD Modeling for Oncology: Focus on Targeted Protein Degradation
Colin Phipps, AbbVie Inc. |
16:00 to 16:30 |
Coffee Break/Group Photo
|
16:30 to 17:00 |
Mutant fixation in the presence of a natural enemy (and other stories)
Natalia Komarova, University of California, San Diego, Leoncie ABIZEYIMANA, African Institute for Mathematical Sciences Research and Innovation Center(AIMS RIC) |
17:00 to 17:20 |
Insights into B cell and antibody kinetics against SARS-CoV-2 variants using mathematical modelling
Suzan Farhang-Sardroodi, University of Toronto |
17:20 to 17:40 |
Continuum limit of Moran birth-death and death-birth process: Fisher-waves speeds
Kamran Kaveh, Harvard University |
17:45 to 19:00 |
Reception
|
09:00 to 10:00 |
Mathematical Modelling of Oncolytic Virotherapy
Thomas Hillen, University of Alberta |
10:00 to 10:30 |
Local Vs Nonlocal models for mitochondria swelling
Messoud Efendiev, Helmholtz Zentrum München |
10:30 to 11:00 |
Coffee Break
|
11:00 to 11:20 |
Revolutionizing Medicine with Generative AI: From Data to Discovery
Ali Mahdipour Shirayeh, Princess Margaret Cancer Center, University Health Network |
11:20 to 11:50 |
Guiding model-driven combination dose selection using multi-objective synergy optimization
Jana Gevertz, The College of New Jersey |
11:50 to 12:10 |
A Refined Model for Investigating Acoustic Vaporization Dynamics in a Bubble Encapsulated by a Nonlinear Elastic Shell
Maryam Ghasemi, Queensland University of Technology |
12:10 to 12:30 |
Dedifferentiation and Cellular Plasticity in Cancer: Insights from Hepatocellular Carcinoma and Melanoma
Seemadri Subhadarshini, The Fields Institute |
12:30 to 12:50 |
Modeling Transport and Neuronal Effects of Alzheimer’s Drug Donepezil Hydrochloride
Corina Drapaca, The Pennsylvania State University |
12:50 to 13:00 |
Concluding Remarks
|